Principal Investigator |
Grant Number and Title | Clinical Translational Core | Genetics Core | Translational Neuroscience Core | Neuroimaging Core | Behavior Science Core |
Aggarwal | R21NS096249-01A1: Oscillating Gradient Diffusion MRI and Quantitative Susceptibility Mapping in the Epileptogenic Brain | X | ||||
Atkinson | UL1-TR001079 (NBRU): Chronic Kidney Disease in Chldren Study (CkiD) | X | ||||
Bastian | R01 HD040289: Mechanisms and Rehabilitation of Cerebellar Ataxia | X | ||||
Baumgartner | R01 HL091541: Excitotoxicity in circulatory arrest-brain injury | X | ||||
Bembea | K23 NS076674: Novel methods of Brain Injury Detection and Outcome Prediction in Pediatric ECMO | X | ||||
Bjornsson | DP5 OD017877: Clinical Confirmation of Novel Computational Genetic Elements | X | ||||
Bjornsson | DP5 OD017877: Exploring Kabuki Syndrome as a treatable cause of intellectual disaiblity | X | ||||
Blue/Kannan | R21 NS100085: Dendrimer Therapies for Treatment of Rett Syndrome | X | X | |||
Brasic | JHUSM BriteStar Award: The Feasibility Study of Metabotropic Glutamate Receptor Type 5 Function in Fragile X Syndrome | X | ||||
Budimirovic | Ovid Therapeutics, Inc.: A Phase 2a, Randomized, Double-Blind, Parallel-Group, Proof-of-Concept Study Evaluating the Safety, Tolerability, and Efficacy of OV101 in Fragile X Syndrome | X | ||||
Burd | K08 HD073315: IL-1β Regulation of Perinatal Brain Injury | X | X | |||
Capone | UL1-TR001079 (NBRU): Depression and Sleep Disorders in Adolescents and Young Adults with Down syndrome | X | ||||
Carnell | UL1-TR001079 (NBRU): Neurobehavioral Influences on Body Weight | X | ||||
Cayton Vaught | Edward E. Wallach Research Fellowship Grant and UM1 HG006542: Demystifying Unexplained Recurrent Pregnancy Loss Through Next Generation Sequencing Technologies | X | ||||
Celnik | R01 HD053793: Novel Strategies to enhance motor function after stroke | X | ||||
Celnik | R01 HD073147: Understanding motor behavior after stroke | X | ||||
Cheng | K01 AA020873: Neuroimaging of Eyeblink Conditioning in Subjects with Alcohol Use Disorders | X | ||||
Comi | Faneca 66 Foundation: Cannabidiol expanded access study in medically refractory Sturge-Weber syndrome | X | ||||
Comi | Faneca 66 Foundation: Trial of sirolimus for cognitive impairments in Sturge-Weber syndrome | X | ||||
Cutting | R01 DK044003: Molecular genetics of cystic fibrosis: Creation and characterization of an airway epithelial cell line for stable expression of exogenous genes | X | ||||
Edden | Brian’s Hope Foundation: Nanodendrimer-Based Targeted Delivery of the N-Acetylcysteine for Adrenoleukodystrophy: A Pilot Study to Determine Feasibility of Clinical Translation | X | ||||
Edden | UL1-TR001079 (NBRU): Dysfunction of Sensory Inhibition in Autism | X | ||||
Ehsani | Hopkins Science of Learning Institute: Neurophysiological Measures of Hazard Perception Among Novice and Teenage Drivers | X | ||||
Everett | R01 HD68446: GFAP Biomarker of Whole Body Cooling Outcome and Efficacy in the Neonate with HIE | X | X | |||
Ewen | R21 NS091569: Direct Examination of Imitation Based Learning in ASD | X | X | X | ||
Fatemi | R01 NS097511: Targeted Therapies for Neonatal White Matter Injury | X | X | |||
Fatemi | Brian’s Hope Foundation: Nanodendrimer-Based Targeted Delivery of the N-Acetylcysteine for Adrenoleukodystrophy: A Pilot Study to Determine Feasibility of Clinical Translation | X | ||||
Fatemi | A Cure for Ellie Foundation: Characterization of the Natural History of Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation | X | ||||
Findling | R01 MH073967: Longitudinal Assessment of Manic Symptoms | X | X | |||
Findling | NCT02674633: Software Treatment for Actively Reducing Severity of ADHD (STARS-ADHD) | X | ||||
Findling | Supernus Pharmaceuticals, SPN810P301: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Molindone Hydrochloride Extended-Release Tablets for the Treatment of Impulsive Aggression in Pediatric Patients with Attention Deficit/Hyperactivity Disorder (ADHD) in Conjunction with Standard ADHD Treatment Objectives | X | X | |||
Findling | Dasotraline Pediatric Extension Study | X | ||||
Findling | Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity Disorder | X | ||||
Germain-Lee | R21 HD078864: The Role of G Protein-Coupled Signaling in Neurocognitive and Psychosocial Abnormalities | X | ||||
Hagopian | R01 HD076653: Delineating subtypes of self-injurious behavior maintained by automatic reinforcement | X | ||||
Hardwick | R01 NS083373: Mechanisms of Neurodegeneration | X | ||||
Harris | Rubenstein Taybi Syndrome Foundation: Characterizing the Neurocognitive and Neurophysiologic Phenotype of Rubinstein-Taybi Syndrome | X | X | X | ||
Hoover-Fong/Gunay-Aygun | 03-HG-0264, NCT00068224: Clinical and Molecular Investigations into Ciliopathies | X | ||||
Jacobson | PCORI Research Institute: Surviving Cancer, Thriving in Life: Health-related Quality of Life after Pediatric Cancer | X | ||||
Jacobson | PCORI Research Institute: Surviving Cancer, Thriving in Life: Health-related Quality of Life after Pediatric Cancer | X | ||||
Johnson | U01 NS038455: Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) | X | ||||
Johnston | 2K12 NS001696: Neurology Sciences Academic Development Award (NSADA) | X | X | |||
Johnston | Kennedy Krieger Institute-Johns Hopkins Medicine Interdisciplinary Cerebral Palsy (CP) Center of Research Excellence (KKI-JHM CPCRE): Nanomedicine-Based Therapy for Perinatal White Matter Injury | X | X | X | ||
Kadam | R01 HD090884: Mechanisms Regulating KCC2 Hypofunction During Refractory Seizures in a Mouse Model of Ischemic Neonatal Seizures | X | ||||
Kamiya/Pletnikov | R01 DA041208: Molecular Mechanism of Astrocytic Vulnerability to Adolescent Cannabis Use | X | ||||
Kannan | R01 HD069562: Mechanisms and Novel Therapy in Intrauterine Inflammation Induced Brain Injury | X | ||||
Kannan | R01 NS093416: Targeting Glutamate Carboxypeptidase in Perinatal Brain Injury | X | X | |||
Keefer | Private Donor: A Pilot Investigation of a Novel Child/Parent Mindfulness Intervention to Improve Emotional Dysregulation in Children with Autism Spectrum Disorders | X | ||||
Krinsky-McHale/Silverman | P01 HD035897: Aging and Dementia in Adults with Down syndrome. Subproject 2: (8402) Validation of Criteria for Identifying “MCI” in Adults with Down syndrome. | X | X | |||
Lance | 1K23HL133455: Neuroimaging, Protein Biomarkers, and Neurodevelopment in Very Young Children with Sickle Cell Disease | X | X | X | ||
Landa | R01 MH059630: Autism social and communication predictors in siblings | X | ||||
Laterra | R01 NS076759: Suppression of Glioblastoma Stem Cells by Kruppel-Like Factor 9 | X | ||||
Laterra | R01 NS096754: Chromatin Modifications in GBM-Propagating Cells | X | X | |||
Lee | R01 NS093213: Cell extrinsic factors’ roles on direct conversion to human induced neural crest | X | ||||
Li | R35 GM118172: Cellular Dynamics in Division, Motility, and Evolutionary Adaptation | X | ||||
Lin | UL1-TR001079 (NBRU): Noninvasive imaging and functional correlation of intracranial pial angiomatosis (SWS) | X | ||||
Maegawa | R01 NS079655: Development of an HTS assay for a neurological lysosomal disease | X | ||||
Mahone | R01 HD068425: Development of ADHD in Preschool Children: Neuroimaging and Behavioral Correlates | X | X | |||
Mahone | UL1-TR001079 (NBRU): DNA Methylation in Children with ADHD and/or Dyslexia | X | ||||
Mahone | Maryland State Department of Education (MSDE): Improving Equity in Access and Opportunity for Students with Disabilities | X | ||||
Mahone | Maryland State Department of Education (MSDE): School-Based Uses of Applied Behavior Analysis: Open Online Modules for Teachers, Administrators, and Special Education Student Support Staff | X | ||||
Mahone | Department of Education (DOE): Neuroscience of Learning and the Learner | X | ||||
Meador | U01 NS038455: Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) | X | ||||
Miller | R01 EB020062: Neurogenerative and Neurodevelopmental Subcortical Shape Diffeomorphometry | X | X | |||
Moler | U01 HL094345: Therapeutic Hypothermia After Pediatric Cardiac Arrest: A Randomized Controlled Trial (THAPCA) | X | X | |||
Mostofsky | R01 MH078160: 1/2 Anamalous Motor Physiology in ADHD | X | X | |||
Mostofsky | R01 MH085328: Adolescent Changes in Brain and Behavior in Boys and Girls with ADHD of deficient response control in ADHD | X | X | |||
Mostofsky/Gilbert | R01 NS096207: GABAergic Sensorimotor Dysfunction in Tourette Syndrome | X | X | |||
Naidu | R01 FD004247: PH2 Study of dextromethorpan in the treatment of Rett syndrome | X | X | X | X | |
Nebel | K01MH109766: Visual-Motor Development in Infants at High Risk for Autism | X | ||||
Northington | R01 HD070996: Mechanisms of hypothermic neuroprotection in neonates | X | X | |||
Pelled | R01 NS072171: The role of transcallosal pathway to neuroplasticity following nerve injury | X | ||||
Pevsner | U01 MH106884: Role of somatic mosaicism in autism, schizophrenia and bipolar disorder brain | X | ||||
Pevsner | UL1-TR001079 (NBRU): DNA in Children with Developmental Disabilities | X | ||||
Pletnikov | R01 MH083728: DISC1 in Neuron-Astrocyte Interactions in Neurodevelopment | X | ||||
Pritchard | R03 EB023359: Role of Peripheral and Brain Iron in the Development of Attention and Cognitive Control | X | X | |||
Puts | K99 MH107719: A Multimodal Investigation of Inhibitory Dysfunction in Autism Spectrum Disorder | X | ||||
Reeves | R01 HD038384: Genomic Approaches to Aneuploidy | X | ||||
Reti | R21 HD092915: Neuromodulation Treatment for Self-Injurious Behavior Associated with Intellectual and Developmental Disabilities | X | ||||
Robertson | 5U01NS081041-02: Approaches and Decisions in Acute Pediatric TBI (ADAPT) | X | ||||
Rosch | K23 MH101322: Delay Discounting in Children with ADHD: Neuroimaging and Behavioral Correlates | X | X | |||
Ruble/Jacobson | Saint Baldrick’s Foundation: Sleep and Neurocognitive Outcomes in Childhood ALL Survivors | X | ||||
Sadowsky | Ekso Bionics, 105333: Adherence to Home-Based Functional Electrical Stimulation (FES) Exercise in Patients with Spinal Cord Injury (SCI) | X | X | |||
Salpekar | NCT03371836: Use of Clobazam in Treating Anxiety Comorbid with Pediatric Epilepsy | X | X | |||
Scafidi | K08 NS069815: Metabolic dysfunction and neuroprotection after pediatric head injury | X | ||||
Schupf/Lott/Silverman | U01 AG051412: Biomarkers of Alzheimer’s disease in adults with Down syndrome | X | X | X | X | |
Schupf/Silverman | P01 HD035897: Aging and Dementia in Adults with Down syndrome. Subproject 4: (8404) Genetic Epidemiology of Alzheimer’s Disease in Down syndrome | X | ||||
Seymour | K23 MH107734: Neurobehavioral correlates of frustration in ADHD | X | X | |||
Silverman | P01 HD035897: Aging and Dementia in Adults with Down syndrome | X | ||||
Singer | Tourette Association of America (TAA): Home-based Behavioral Intervention for Tics, Comparison of Home-based DVD Therapy and Psychologist-directed CBIT Treatment | X | ||||
Song | Tourette Association of America (TAA): Home-based Behavioral Intervention for Tics, Comparison of Home-based DVD Therapy and Psychologist-directed CBIT Treatment | X | ||||
Suskauer | UL1-TR001079 (NBRU): Neural Basis of Impairments in Response Inhibition and Processing Speed | X | ||||
Suskauer | R01 HD090266: Subtle Motor Functioning and Functional Connectivity in Youth Medically Cleared After Mild TBI | X | X | |||
Tifft | NHGRI Rare Impact Award: Diagnosis and Segregation of Undiagnosed Disease | X | ||||
Tycko/Silverman | P01HD035897: Aging and dementia in adults with Down syndrome. Subproject 3: (8403) Epigenetic Modifiers in Down syndrome | X | ||||
Valle | UM1 HG006542: Baylor-Johns Hopkins Center for Mendelian Genetics | X | X | |||
Vernon | K08HD073492: Metabolic studies in disorders of branch chain amino acid metabolism | X | X | |||
Wagner | U54 HD060848: Biomarkers for Therapy of FSHD | X | ||||
Wagner | NCT01847573: Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy | X | ||||
Wang | R21NS085358: DHHC 15 palmitoylation modulates striatal dopamine system | X | ||||
Watkins | R21NS091988: Drug Discovery for X-Linked Adrenoleukodystrophy | X | X | |||
Watson | 5R01 HD074757: Sedation Strategy and Cognitive Outcome After Critical Illness in Early Childhood | X | ||||
Wilson | U54HD079123: IDDRC Research Component (6271): Multi-modal Treatment for Neonatal HIE: Hypothermia and Dendrimer Nanotherapy | X | X | X | ||
Wu | R21NS098018: In-Utero Characterization of Embryonic Mouse Brain Development and Injury with MRI | X | ||||
Xia | 5R01NS091165: Effect of IDH1 Mutation on Chromosome Instability | X | X | |||
Yau | R01EY014596: Melanopsin Photoreception and Signaling | X | ||||
Zhang | R01HD074593: Imaging neonatal hypoxic ischemic injury | X |